<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M808</article-id>
      <article-id pub-id-type="publisher-id">molbank-2013-M808</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>6-[5-Chloro-2-(trifluoromethyl)phenyl]-3-fluoro-2-methylpyridine</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Manojkumar</surname>
            <given-names>Karikere Ekanna</given-names>
          </name>
          <xref rid="af1-molbank-2013-M808" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sreenivasa</surname>
            <given-names>Swamy</given-names>
          </name>
          <xref rid="af1-molbank-2013-M808" ref-type="aff">1</xref>
          <xref rid="c1-molbank-2013-M808" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nadigar</surname>
            <given-names>Mohan Revanasiddappa</given-names>
          </name>
          <xref rid="af1-molbank-2013-M808" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harikrishna</surname>
            <given-names>Tadimety</given-names>
          </name>
          <xref rid="af2-molbank-2013-M808" ref-type="aff">2</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2013-M808"><label>1</label>Center for Advanced Materials, Department of Chemistry, Tumkur University, Tumkur-572103, Karnataka, India</aff>
      <aff id="af2-molbank-2013-M808"><label>2</label>Tadimety Aromatics Pvt. Ltd, Hirehalli Industrial Area, Tumkur-572168, India</aff>
      <author-notes>
        <corresp id="c1-molbank-2013-M808"><label>*</label> Author to whom correspondence should be addressed; E-Mail: <email>drsreenivasa@yahoo.co.in.</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>09</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2013</year>
      </pub-date>
      <volume>2013</volume>
      <issue>4</issue>
      <elocation-id>M808</elocation-id>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>07</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>09</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2013 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>Suzuki coupling reaction of 5-fluoro-6-methylpyridin-2-ylboronic acid (1) with 4-chloro-2-iodo-1-(trifluoromethyl)benzene (2) in the presence of dikis and K<sub>2</sub>CO<sub>3</sub> produce C-C coupled new title compound 6-(5-chloro-2-(trifluoromethyl)phenyl)-3-fluoro-2-methylpyridine (3). The structure of the newly synthesized compound has been confirmed by IR, <sup>1</sup>H-NMR, <sup>13</sup>C-NMR, LC-MS and CHN analysis.</p>
      </abstract>
      <kwd-group>
        <kwd>Suzuki coupling</kwd>
        <kwd>5-fluoro-6-methylpyridin-2-ylboronic acid</kwd>
        <kwd>4-chloro-2-iodo-1-(trifluoromethyl)benzene</kwd>
        <kwd>bis(triphenylphosphine)palladium(II) dichloride (dikis)</kwd>
        <kwd>1,4-dioxane</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>The fluorine atom plays a very important role in the chemical and biological field [<xref ref-type="bibr" rid="B1-molbank-2013-M808">1</xref>]. After nitrogen, fluorine occupies the position of the second most important hetero atom in life science research. Overall 10%&#x2013;15% of newly synthesised pharmaceutical drugs and 30%&#x2013;40% of newly registered agrochemicals contain one or more fluorine atom.[<xref ref-type="bibr" rid="B2-molbank-2013-M808">2</xref>] Generally, halogenated heterocyclic compounds like pyridine and pyrimidine derivatives are associated with antibacterial [<xref ref-type="bibr" rid="B3-molbank-2013-M808">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2013-M808">4</xref>], antioxidant [<xref ref-type="bibr" rid="B5-molbank-2013-M808">5</xref>], antitumor [<xref ref-type="bibr" rid="B6-molbank-2013-M808">6</xref>,<xref ref-type="bibr" rid="B7-molbank-2013-M808">7</xref>], anticancer, fungicidal [<xref ref-type="bibr" rid="B8-molbank-2013-M808">8</xref>] and anti-inflammatory agents [<xref ref-type="bibr" rid="B9-molbank-2013-M808">9</xref>]. Some of the halogenated pyridines are used as anti-colorectal cancer compounds [<xref ref-type="bibr" rid="B10-molbank-2013-M808">10</xref>], anti-hypoglycemic and antihypertensive agents [<xref ref-type="bibr" rid="B11-molbank-2013-M808">11</xref>]. Due to the wide application of fluorinated pyridines and potency of fluorine atom, it was thought worthwhile to prepare a new fluorinated pyridine.</p>
    <sec sec-type="methods">
      <title>Experimental</title>
      <p>All reagents were purchased from commercial sources and used without further purification. Melting point was determined in one end open capillary tube on a liquid paraffin bath and was not corrected. Reaction was carried out under an inert nitrogen atmosphere. Mass spectra, <sup>1</sup>H-NMR and <sup>13</sup>C-NMR spectra were recorded for the compound on Agilent Mass spectrometer, Bruker Avance II (399.65 MHz, <sup>1</sup>H-NMR; 100.50 MHz, <sup>13</sup>C-NMR) instruments, respectively. Chemical shifts were reported in parts per million (ppm) using tetramethylsilane (TMS) as an internal standard and Elemental (C, H and N) analysis was performed on an Elementar vario MICRO cube.</p>
      <sec>
        <title>Synthesis of 6-[5-Chloro-2-(trifluoromethyl)phenyl]-3-fluoro-2-methylpyridine <italic>(<bold>3</bold>)</italic></title>
        <p>The title compound (<bold>3</bold>) was synthesized according to a known procedure reported for the synthesis of isomeric compound 6-[4-chloro-2-(trifluoromethyl)phenyl]-3-fluoro-2-methylpyridine [<xref ref-type="bibr" rid="B12-molbank-2013-M808">12</xref>] (<xref ref-type="scheme" rid="molbank-2013-M808-sch001">Scheme 1</xref>.). A mixture of 5-fluoro-6-methylpyridin-2-ylboronic acid (<bold>1</bold>) (1.0 g, 6.49 mmol), 1,4-dioxane (16 mL) and water (8 mL) was prepared in a round bottom flask at room temperature under nitrogen atmosphere. The reaction mixture was degassed with argon for 15 min, K<sub>2</sub>CO<sub>3</sub> (1.34 g, 9.74 mmol) and Bis(triphenylphosphine)palladium(II) dichloride (dikis) (0.22 g, 0.32 mmol)  were added and degassed for 25 min. To this solution, 4-chloro-2-iodo-1-(trifluoromethyl)benzene (<bold>2</bold>) (1.95 g, 6.49 mmol) was added and the reaction mixture was heated for 6 h at 100 &#xB0;C. It was allowed to cool to room temperature and diluted with ethyl acetate, filtered over celite, washed with ethyl acetate. The filtrate was washed with water and brine solution. Organic layer was dried over anhydrous MgSO<sub>4</sub> and concentrated to give the crude product which was further purified by column chromatography using petroleum ether and ethyl acetate (7:3) as eluent to get the title compound (<bold>3</bold>) as a white solid with R<sub>f</sub> = 0.64.</p>
        <p>Yield: 1.6 g (86%).</p>
        <p>Melting point: 141&#x2013;143 &#xB0;C.</p>
        <p>MS: <italic>m/z</italic>: 290.2 (M<sup>+</sup> + 1).</p>
        <p>IR: &#x3BD;<sub>max</sub>/cm<sup>&#x2212;1</sup>: 3091&#x2013;2957 (aromatic C-H stretching), 1314&#x2013;1221 (CF<sub>3</sub> stretching), 1618 and 1431 (C=C stretching).</p>
        <p><sup>1</sup>H-NMR (CDCl<sub>3</sub>) &#x3B4; ppm: 7.74 (d, <italic>J</italic> = 1.9 Hz 1H, Ar-H), 7.58 (dd, <italic>J</italic> = 8.3 Hz and <italic>J</italic> = 1.9 Hz 1H, Ar-H), 7.44&#x2013;7.34 (m, 2H, Ar-H), 7.24&#x2013;7.21 (m, 1H, Ar-H), 2.57 (d, <italic>J</italic> = 2.7, 3H, Ar-CH<sub>3</sub>).</p>
        <p><sup>13</sup>C-NMR (DMSO-d<sub>6</sub>): &#x3B4; ppm: 158.6, 156.1, 151.5, 146.5, 137.8, 134.5, 133.0, 131.6, 126.6 CF<sub>3</sub>, 124.5, 122.6, 121.8, 17.9.</p>
        <p>Elemental analysis: Calculated for: C<sub>13</sub>H<sub>8</sub>ClF<sub>4</sub>N: C, 53.91%; H, 2.78%; N, 4.84%. Found: C, 53.89%; H, 2.76%; N, 4.83%.</p>
      </sec>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2013-M808">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2013-M808-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2013-M808-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2013-M808-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2013-M808-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
    </app>
</app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>We gratefully acknowledge the guidance by S.C. Sharma, Former Vice Chancellor, Tumkur University, Tumkur.</p>
    </ack>
    <notes>
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2013-M808">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Filler</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Saha</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Flurine in medicinal chemistry: A century of progress and a 60-year retrospective of selected highlights</article-title>
          <source>Future Med. Chem.</source>
          <year>2009</year>
          <volume>1</volume>
          <fpage>777</fpage>
          <lpage>791</lpage>
          <pub-id pub-id-type="doi">10.4155/fmc.09.65</pub-id>
          <pub-id pub-id-type="pmid">21426080</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2013-M808">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Ni</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Selective fluoroalkylation of organic compounds by tackling the &#x201C;Negative Fluorine Effect&#x201D;</article-title>
          <source>Top Curr. Chem.</source>
          <year>2012</year>
          <volume>308</volume>
          <fpage>25</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">21898204</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2013-M808">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jian</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Shenghong</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Baoan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Deyu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ming</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Linhong</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antibacterial activity against ralstonia solanacearum for novel hydrazone derivatives containing a pyridine moiety</article-title>
          <source>Chem. Cent. J.</source>
          <year>2012</year>
          <volume>6</volume>
          <fpage>1</fpage>
          <lpage>5</lpage>
        </citation>
      </ref>
      <ref id="B4-molbank-2013-M808">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chavhan</surname>
              <given-names>N.M.</given-names>
            </name>
            <name>
              <surname>Badadhe</surname>
              <given-names>P.V.</given-names>
            </name>
            <name>
              <surname>Joshi</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Mandhane</surname>
              <given-names>P.G.</given-names>
            </name>
            <name>
              <surname>Gill</surname>
              <given-names>C.H.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and Biological Evaluation of Some Heterocycles from 1-Phenyl-3-(pyridine-3-yl)-1H-pyrazole-4-carbaldehyde</article-title>
          <source>Asian J. Chem.</source>
          <year>2010</year>
          <volume>22</volume>
          <fpage>4255</fpage>
          <lpage>4260</lpage>
        </citation>
      </ref>
      <ref id="B5-molbank-2013-M808">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prachayasittikul</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Suksrichavalit</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Isarankura-Na-Ayudhya</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ruchirawat</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Prachayasittikul</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <article-title>Antimicrobial and antioxidative activities of 1-adamantylthio derivatives of 3-substituted pyridines</article-title>
          <source>EXCLI</source>
          <year>2008</year>
          <volume>7</volume>
          <fpage>63</fpage>
          <lpage>70</lpage>
        </citation>
      </ref>
      <ref id="B6-molbank-2013-M808">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghorab</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Ragab</surname>
              <given-names>F.A.</given-names>
            </name>
            <name>
              <surname>Heiba</surname>
              <given-names>H.I.</given-names>
            </name>
            <name>
              <surname>Youssef</surname>
              <given-names>H.A.</given-names>
            </name>
            <name>
              <surname>El-Gazzar</surname>
              <given-names>M.G.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of novel pyrazole and pyrimidine derivatives bearing sulfonamide moiety as antitumor and radiosensitizing agents</article-title>
          <source>Med. Chem. Res.</source>
          <year>2012</year>
          <volume>21</volume>
          <fpage>1376</fpage>
          <lpage>1386</lpage>
          <pub-id pub-id-type="doi">10.1007/s00044-011-9653-x</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2013-M808">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zheng</surname>
              <given-names>Q.Z.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X.M.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Jiao</surname>
              <given-names>Q.C.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>H.L.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents</article-title>
          <source>Bioorg. Med. Chem.</source>
          <year>2010</year>
          <volume>18</volume>
          <fpage>7836</fpage>
          <lpage>7841</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmc.2010.09.051</pub-id>
          <pub-id pub-id-type="pmid">20947362</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2013-M808">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tumkevicius</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Urbonas</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Vainilavicius</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of methyl esters of 5-amino-4-(substituted amino)-2-methylthio-7H-pyrrolol[2,3-d]-pyrimidine-6-carboxylic acids</article-title>
          <source>Chem. Heterocycl. Compd.</source>
          <year>2000</year>
          <volume>36</volume>
          <fpage>841</fpage>
          <lpage>846</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02256920</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2013-M808">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prasad</surname>
              <given-names>Y.R.</given-names>
            </name>
            <name>
              <surname>Rajasekhar</surname>
              <given-names>K.K.</given-names>
            </name>
            <name>
              <surname>Shankarananth</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>K.N.</given-names>
            </name>
            <name>
              <surname>Pradeepkumar</surname>
              <given-names>G.S.S.</given-names>
            </name>
            <name>
              <surname>Nagendrababu</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis, antiinflammatory and antimicrobial evaluation of 2-phenyl-4,6-diaryl substituted pyrimidine derivatives</article-title>
          <source>J. Pharm. Res.</source>
          <year>2010</year>
          <volume>3</volume>
          <fpage>2480</fpage>
          <lpage>2482</lpage>
        </citation>
      </ref>
      <ref id="B10-molbank-2013-M808">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gopalakrishnan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vadivel</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Pon Sathieshkumar</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Praba</surname>
              <given-names>M.S.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis, molecular docking and ADME prediction of some pyridine and pyrimidine derivatives as anti-colorectal cancer drugs</article-title>
          <source>J. Chem. Pharm. Res.</source>
          <year>2010</year>
          <volume>2</volume>
          <fpage>60</fpage>
          <lpage>66</lpage>
        </citation>
      </ref>
      <ref id="B11-molbank-2013-M808">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dolzhenko</surname>
              <given-names>A.V.</given-names>
            </name>
            <name>
              <surname>Kolotova</surname>
              <given-names>N.V.</given-names>
            </name>
            <name>
              <surname>Koz&#x2019;minykh</surname>
              <given-names>V.O.</given-names>
            </name>
            <name>
              <surname>Syropyatov</surname>
              <given-names>B.Y.</given-names>
            </name>
            <name>
              <surname>Kotegov</surname>
              <given-names>V.P.</given-names>
            </name>
            <name>
              <surname>Godina</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Substituted amides and hydrazides of dicraboxylic acids. Part 12.<sup>1</sup> Synthesis and hypoglycemic and hypertensive activity of some pyridylamides and acylhydrazides of malic and citraconic acid</article-title>
          <source>Pharm. Chem. J.</source>
          <year>2002</year>
          <volume>36</volume>
          <fpage>174</fpage>
          <lpage>176</lpage>
          <pub-id pub-id-type="doi">10.1023/A:1019824419554</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2013-M808">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sreenivasa</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Manojkumar</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Suchetan</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Mohan</surname>
              <given-names>N.R.</given-names>
            </name>
            <name>
              <surname>Palakshamurthy</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Srinivas</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Velmurgand</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>6-[4-Chloro-2-(trifluoromethyl)phenyl]-3-fluoro-2-methylpyridine</article-title>
          <source>Acta Cryst.</source>
          <year>2012</year>
          <pub-id pub-id-type="doi">10.1107/S1600536812046211</pub-id>
          <pub-id pub-id-type="pmid">23476202</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Scheme</title>
      <fig id="molbank-2013-M808-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2013-M808-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthetic route for the title compound, 6-[5-chloro-2-(trifluoromethyl)phenyl]-3-fluoro-2-methylpyridine (<bold>3</bold>).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2013-M808-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
